Targeted Cationic Liposomes, Technologies, and Developments

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2003, Volume 27, Issue 12

The author provides a brief review of tumor-specific and liver-targeted cationic liposomes and the strategies for the development of liposome-ligand complexes.

Related Content:

Drug DeliveryDevelopmentPharmaceutical Technology-12-02-2003
Takeda Gets Approval in Japan for Entyvio Subcutaneous Injection
Moderna and Generation Bio Announce Strategic Collaboration
Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development